Kaisa J. Kurkinen

Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren

Tuija Tapaninen, Janne T. Backman, Kaisa J. Kurkinen et al. · The Journal of Clinical Pharmacology · 2010 · 60 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe

Janne T. Backman, Johanna Honkalammi, Mikko Neuvonen et al. · Drug Metabolism and Disposition · 2009 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +17

Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S‐Ketamine and Less on Intravenous S‐Ketamine

Marko Peltoniemi, Teijo I. Saari, Nora Hagelberg et al. · Basic & Clinical Pharmacology & Toxicology · 2012 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

No significant effect of <i>ABCB1</i> haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin

Jenni E. Keskitalo, Kaisa J. Kurkinen, Mikko Neuvonen et al. · British Journal of Clinical Pharmacology · 2009 · 55 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S‐ketamine

Nora Hagelberg, Marko Peltoniemi, Teijo I. Saari et al. · European Journal of Pain · 2009 · 54 citations

Medicine, Pharmacokinetics, Pharmacology +16